血压与2型糖尿病患者心肾事件及全因死亡的关系:韩国国民健康保险数据库研究
基于韩国国民健康保险系统数据库,纳入2007年定期体检的2型糖尿病患者326593例,按收缩压和舒张压各分7组,分析血压与心肾事件及全因死亡的风险比。与收缩压120-129 mmHg、舒张压75-79 mmHg相比,收缩压≥130 mmHg和舒张压≥80 mmHg与主要心血管不良事件风险比升高相关;收缩压120-129 mmHg和舒张压75-79 mmHg的全因死亡风险比最低。作者结论认为主要心血管不良事件和死亡风险较低的最佳血压切点可能为收缩压120-129 mmHg、舒张压75-79 mmHg,而较低的收缩压可能对肾脏病高风险患者有帮助。
要点
- 与收缩压120-129 mmHg、舒张压75-79 mmHg相比,收缩压≥130 mmHg和舒张压≥80 mmHg与主要心血管不良事件风险比升高相关。
- 收缩压120-129 mmHg和舒张压75-79 mmHg与全因死亡风险比最低相关。
- 血压过低(收缩压/舒张压<120/70 mmHg)和血压过高(收缩压/舒张压≥130/80 mmHg)均与全因死亡风险比升高相关;收缩压越低,肾脏事件风险比越低。
核心结论
- 在2型糖尿病患者中,与主要心血管不良事件和死亡发生率较低相关的最佳血压切点可能为收缩压120-129 mmHg和舒张压75-79 mmHg。
- 较低的收缩压可能对肾脏病高风险的2型糖尿病患者有帮助。
研究设计与样本
- 利用韩国国民健康保险系统数据库,提取2007年1月1日至2007年12月31日定期体检的2型糖尿病患者数据(N=1800073),最终纳入326593例。
- 研究人群按观察到的收缩压(<110、110-119、120-129、130-139、140-149、150-159、160-169、≥170 mmHg)和舒张压(<65、65-69、70-74、75-79、80-84、85-89、≥90 mmHg)分组,分析各血压类别心肾事件和全因死亡的风险比(HR)。
主要发现
- 与收缩压120-129 mmHg和舒张压75-79 mmHg相比,收缩压≥130 mmHg和舒张压≥80 mmHg与主要心血管不良事件(MACEs)的HR升高相关。
- 收缩压120-129 mmHg和舒张压75-79 mmHg与全因死亡的HR最低相关。
- 较低的血压(收缩压/舒张压<120/70 mmHg)和较高的血压(收缩压/舒张压≥130/80 mmHg)均与全因死亡的HR升高相关。
- 与主要心血管不良事件相反,收缩压越低,肾脏事件的HR越低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The relationship of blood pressure (BP) with cardio-renal events and all-cause mortality in type 2 diabetes mellitus (T2DM) is still controversial. OBJECTIVE: To investigate the optimal BP target in Korean individuals with T2DM. METHODS: Using the Korean National Health Insurance System database, data of individuals with T2DM who underwent regular health checks from January 1, 2007, to December 31, 2007, were extracted (N = 1 800 073). Among them, a total of 326 593 individuals were included in the final study. The study population was divided into 7 groups according to their observed systolic blood pressure (SBP) (<110, 110-119, 120-129, 130-139, 140-149, 150-159, 160-169, and ≥170 mmHg) and diastolic blood pressure (DBP) (<65, 65-69, 70-74, 75-79, 80-84, 85-89, and ≥90 mmHg). Hazard ratios (HRs) of cardio-renal events and all-cause mortality according to BP categories were analyzed. RESULTS: Compared with SBP of 120-129 mmHg and DBP of 75-79 mmHg, SBP of ≥130 mmHg and DBP of ≥ 80 mmHg were associated with an increase in HR of major cardiovascular adverse events (MACEs). SBP of 120-129 mmHg and DBP 75-79 mmHg were associated with the lowest HR of all-cause mortality. Both lower BP (SBP/DBP <120/70 mm) and higher BP (SBP/DBP ≥130/80 mmHg) were associated with an increased HR of all-cause mortality. Contrary to MACE, the lower the SBP, the lower the HR of renal events. CONCLUSION: In patients with T2DM, the optimal cutoff value of BP associated with a lower incidence of MACE and mortality may be 120-129 mmHg for SBP and 75-79 mmHg for DBP. However, lower SBP may be helpful for T2DM patients with a high risk of renal disease.
引用
- Kim BY, Lee JI, Lee HM, et al. Association of Blood Pressure With Cardio-Renal Events and Mortality in Type 2 DM: A National Health Insurance Database. J Clin Endocrinol Metab. 2023. PMID: 37431631. doi:10.1210/clinem/dgad404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。